Study #ID01-022
USE OF THE CA 125 ALGORITHM FOR THE EARLY DETECTION OF OVARIAN CANCER IN LOW RISK WOMEN
MD Anderson Study Status
Enrolling
Treatment Agent
N/A
Description
The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Information and next steps
Disease:
Ovarian Cancer
Study phase:
Not applicable
Physician name:
Karen Lu
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.